InsiderTrades.com logo
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

APGE Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $29,750,000.00
Insider Selling (Last 12 Months): $0.00

Apogee Therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at Apogee Therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Apogee Therapeutics Share Price & Price History

Current Price: $21.30
Price Change: ▲ Price Increase of +0.62 (3.00%)
As of 09/29/2023 01:00 AM ET

This chart shows the closing price history over time for APGE up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Safest Option in Trades!
From Tradewins   |   Ad
If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!
Click here now!

Apogee Therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/13/2023Nimish P ShahDirectorBuy1,750,000$17.00$29,750,000.001,750,000View SEC Filing Icon  
See Full Table
It’s finally here…
From ProTrading Research   |   Ad
Our analysts have finally finished the report we’ve all been waiting for.

The Top Five Ai Stocks that are part of the new AI Gold Rush happening in the world right now.

5 years from now, you just might wish you’d gotten in early on these stocks.
Click here to get the names of all 5 companies

SEC Filings (Institutional Ownership Changes) for Apogee Therapeutics (NASDAQ:APGE)

32.06% of Apogee Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Apogee Therapeutics logo
Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.
Read More on Apogee Therapeutics

Today's Range

Now: $21.30
Low: $20.30
High: $21.46

50 Day Range

MA: $22.25
Low: $19.98
High: $24.71

52 Week Range

Now: $21.30
Low: $18.99
High: $25.54

Volume

155,660 shs

Average Volume

462,378 shs

Market Capitalization

$1.08 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of Apogee Therapeutics?

Apogee Therapeutics' top insider shareholders include:
  1. Nimish P Shah (Director)
Learn More about top insider investors at Apogee Therapeutics.
It’s finally here…
From ProTrading Research   |   Ad
Our analysts have finally finished the report we’ve all been waiting for.

The Top Five Ai Stocks that are part of the new AI Gold Rush happening in the world right now.

5 years from now, you just might wish you’d gotten in early on these stocks.
Click here to get the names of all 5 companies